RenovoRx CEO granted 946,107 stock options

RenovoRx, Inc. Chief Executive Officer Shaun Bagai received a grant of stock options covering 946,107 shares of common stock at an exercise price of $0.98 per share.

Rhea-AI Filing Summary

RenovoRx, Inc. Chief Executive Officer Shaun Bagai received a grant of stock options covering 946,107 shares of common stock at an exercise price of $0.98 per share. The grant was approved by the Compensation Committee.

The options vest over four years at 1/48 per month starting January 1, 2026, becoming fully vested on January 1, 2030, and expiring on April 3, 2036. They are only exercisable when there is an effective registration statement covering the underlying shares.

Insider Trade Summary

Grant/Award: 946,107 shares

Grant/Award 1 txn

Insider Bagai Shaun

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	946,107	$0.00	$0.00

Holdings After Transaction: Stock Option — 946,107 contracts (Direct)

Footnotes (1)

1. F1. On April 3, 2026, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 946,107 shares of the Issuer's common stock (111,621 shares of which are underlying incentive stock options and 834,486 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2026. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2030, and will expire on April 3, 2036.

Key Figures

Option grant size: 946,107 shares Exercise price: $0.98 per share Incentive stock options portion: 111,621 shares +4 more

7 metrics

Option grant size 946,107 shares Stock options granted to CEO covering common stock

Exercise price $0.98 per share Conversion or exercise price of granted stock options

Incentive stock options portion 111,621 shares Shares underlying incentive stock options within total grant

Non-qualified options portion 834,486 shares Shares underlying non-qualified stock options within total grant

Vesting schedule 1/48 per month Monthly vesting over four years starting January 1, 2026

Full vesting date January 1, 2030 Date options become fully vested

Expiration date April 3, 2036 Date on which the stock options expire

Key Terms

incentive stock options, non-qualified stock options, vesting over four years at a rate of 1/48 per month, effective registration statement, +1 more

5 terms

incentive stock options financial

"111,621 shares of which are underlying incentive stock options"

Incentive stock options are a type of employee stock option that gives eligible workers the right to buy company shares at a fixed price later on, often below future market value. They matter to investors because they align employee incentives with company performance, can dilute existing ownership when exercised, and create potential tax advantages for option holders if certain holding-time rules are met — think of them as a coupon to buy stock at today’s price with extra tax rules attached.

non-qualified stock options financial

"834,486 of which are underlying non-qualified stock options"

Non-qualified stock options are a type of employee benefit that gives individuals the right to buy company shares at a set price, usually lower than the market value, within a certain period. Unlike other options that may have special tax advantages, these options are taxed as income when exercised, which can affect how much money the employee or investor ultimately gains. They are important because they can influence company compensation strategies and impact the financial outcomes for employees and investors.

vesting over four years at a rate of 1/48 per month financial

"with such options vesting over four years at a rate of 1/48 per month"

effective registration statement regulatory

"The options will only become exercisable when there is an effective registration statement"

An effective registration statement is a company filing that a securities regulator has approved as meeting disclosure rules, giving the company the legal green light to sell new shares or debt to the public. For investors it matters because the approval signals needed information has been made public and allows offerings that can change a company's cash position, share count and stock liquidity—think of it as a permit that lets a fundraising or public sale go forward.

stock options financial

"was granted stock options to purchase up to 946,107 shares"

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did RenovoRx (RNXT) disclose about CEO Shaun Bagai’s latest equity grant?

RenovoRx disclosed that CEO Shaun Bagai received stock options for 946,107 shares at a $0.98 exercise price. The award was approved by the Compensation Committee and is structured as a long-term incentive with monthly vesting over four years, subject to exercisability conditions.

How many RenovoRx (RNXT) shares are covered by the new stock options?

The new stock option grant covers 946,107 shares of RenovoRx common stock. These comprise 111,621 shares underlying incentive stock options and 834,486 shares underlying non-qualified stock options, providing the CEO with a sizable equity-based compensation opportunity over time.

What are the vesting terms for CEO Shaun Bagai’s RenovoRx (RNXT) stock options?

The options vest over four years at a rate of 1/48 each month, starting January 1, 2026. They become fully vested on January 1, 2030. This structure ties the award to continued service, with no initial cliff and gradual monthly vesting.

When can the newly granted RenovoRx (RNXT) stock options be exercised?

The options can only be exercised when there is an effective registration statement covering the underlying shares. This means exercise is contingent on regulatory effectiveness, in addition to vesting, adding an extra condition before the CEO can purchase shares.

What is the exercise price and expiration date of the RenovoRx (RNXT) CEO stock options?

The stock options have an exercise price of $0.98 per share and expire on April 3, 2036. If not exercised by that date, subject to vesting and registration effectiveness, the options will lapse and cease to be exercisable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/07/2026 - 08:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bagai Shaun

(Last) (First) (Middle)

C/O RENOVORX, INC.

2570 W EL CAMINO REAL, SUITE 320

(Street)

MOUNTAIN VIEW CALIFORNIA 94040

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RenovoRx, Inc. [ RNXT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$0.98	04/03/2026		A		946,107		(1)	(1)	Common Stock	946,107	$0	946,107	D

Explanation of Responses:

1. On April 3, 2026, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 946,107 shares of the Issuer's common stock (111,621 shares of which are underlying incentive stock options and 834,486 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2026. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2030, and will expire on April 3, 2036.

	/s/ Shaun Bagai	04/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)